Understanding the Substrate Specificity of the Heparan Sulfate Sulfotransferases by an Integrated Biosynthetic and Crystallographic Approach

Jian Liu,Andrea F. Moon,Juzheng Sheng,Lars C. Pedersen
DOI: https://doi.org/10.1016/j.sbi.2012.07.004
2012-01-01
Abstract:Heparan sulfates (HSs) have potential therapeutic value as anti-inflammatory and antimetastasis drugs, in addition to their current use as anticoagulants. Recent advances in chemoenzymatic synthesis of HS provide a way to conveniently produce homogenous HS with different biological properties. Crystal structures of sulfotransferases involved in this process are providing atomic detail of their substrate binding clefts and interactions with their HS substrates. In theory, the flexibility of this method can be increased by modifying the specificities of the sulfotransferases based on the structures, thereby producing a new array of products.
What problem does this paper attempt to address?